WHO raises alarm in race to catch up on measles shots to stem outbreaks
About 60-million children missed doses over the Covid-19 period, says immunisation chief Kate O’Brien
19 March 2024 - 19:18
byJennifer Rigby
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Vaccinating children who missed their measles shots during the Covid-19 pandemic is critical, a senior World Health Organisation official said on Tuesday, as outbreaks of the infectious disease increase worldwide.
More than 50 countries have experienced “large and disruptive” measles outbreaks in the past year, twice as many as in 2022, said Kate O’Brien, WHO director of immunisation, at a virtual press conference.
Measles is a contagious viral illness that causes flu-like symptoms and a rash. It can be fatal but is preventable with two doses of vaccine.
Covid-19 hugely disrupted routine vaccination efforts worldwide, and about 60-million children missed their doses over that period, O’Brien said.
She said catch-up efforts were critical.
“It’s now a race between whether the catch-up activities can happen quickly enough or whether the outbreaks will continue to scale,” she said.
On Monday, the US Centers for Disease Control and Prevention also urged people to be vaccinated against measles amid rising cases globally.
WHO experts also backed new ways of using existing vaccines to tackle other disease outbreaks, including the use of the mpox vaccine made by Bavarian Nordic (BAVA.CO) for at-risk children in African countries.
They also recommended the use of the hepatitis E vaccine for all women of childbearing age in conflicts and other emergency settings. The infection, mostly transmitted through contaminated water, can be particularly dangerous for pregnant women.
The vaccine, developed by China’s Xiamen Innovax Biotech, has not been widely used outside China though it has been backed by WHO for use in outbreaks since 2015.
The chair of the WHO’s expert vaccine committee, Hanna Nohynek, told the press conference that the focus on outbreaks was a sign that “the normalcy is starting to be living with outbreaks … that’s kind of alarming.”
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
WHO raises alarm in race to catch up on measles shots to stem outbreaks
About 60-million children missed doses over the Covid-19 period, says immunisation chief Kate O’Brien
Vaccinating children who missed their measles shots during the Covid-19 pandemic is critical, a senior World Health Organisation official said on Tuesday, as outbreaks of the infectious disease increase worldwide.
More than 50 countries have experienced “large and disruptive” measles outbreaks in the past year, twice as many as in 2022, said Kate O’Brien, WHO director of immunisation, at a virtual press conference.
Measles is a contagious viral illness that causes flu-like symptoms and a rash. It can be fatal but is preventable with two doses of vaccine.
Covid-19 hugely disrupted routine vaccination efforts worldwide, and about 60-million children missed their doses over that period, O’Brien said.
She said catch-up efforts were critical.
“It’s now a race between whether the catch-up activities can happen quickly enough or whether the outbreaks will continue to scale,” she said.
On Monday, the US Centers for Disease Control and Prevention also urged people to be vaccinated against measles amid rising cases globally.
WHO experts also backed new ways of using existing vaccines to tackle other disease outbreaks, including the use of the mpox vaccine made by Bavarian Nordic (BAVA.CO) for at-risk children in African countries.
They also recommended the use of the hepatitis E vaccine for all women of childbearing age in conflicts and other emergency settings. The infection, mostly transmitted through contaminated water, can be particularly dangerous for pregnant women.
The vaccine, developed by China’s Xiamen Innovax Biotech, has not been widely used outside China though it has been backed by WHO for use in outbreaks since 2015.
The chair of the WHO’s expert vaccine committee, Hanna Nohynek, told the press conference that the focus on outbreaks was a sign that “the normalcy is starting to be living with outbreaks … that’s kind of alarming.”
Reuters
Measles outbreaks run riot across world with children most at risk
Aspen and Biovac to bid for vaccine contracts under new $1bn Africa package
How SA’s mRNA hub is teaching the world about preparing for the next pandemic
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Related Articles
Measles outbreaks run riot across world with children most at risk
Aspen and Biovac to bid for vaccine contracts under new $1bn Africa package
Stigma and regulatory barriers delay mpox response
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.